Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-like protein family member 10A (RASL10A) is a small GTPase predicted to enable GTP binding and GTPase activity, localizing primarily to the nucleolus and plasma membrane. It acts as a potent inhibitor of cellular proliferation, suggesting a possible role in tumor suppression. The gene has been implicated in inherited diseases such as Joubert syndrome 8 and Bardet-Biedl syndrome 19. There are currently no drugs reported to interact directly with this protein, and it is not recognized as a validated therapeutic target in existing public datasets
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-like protein family member 10A (RASL10A).